AEON Biopharma (AEON) Prepaid Assets (2021 - 2026)
AEON Biopharma (AEON) posted Prepaid Assets of $392000.0 for Q4 2025, down 73.6% sequentially from $1.5 million in Q3 2025, and down 75.14% YoY from $1.6 million in Q4 2024.
AEON Biopharma (AEON) Prepaid Assets (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Prepaid Assets for 5 years, with the latest figure at $392000.0 in Q4 2025.
- Quarterly Prepaid Assets fell 75.14% year-over-year to $392000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $392000.0 (down 75.14% YoY) and the FY2025 annual result came in at $392000.0, down 75.14% from the prior year.
- Prepaid Assets retreated to $392000.0 in Q4 2025 per AEON's latest filing, from $1.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.9 million in Q1 2025 and troughed at $85293.0 in Q1 2023.
- A 5-year average of $757554.6 and a median of $484500.0 in 2024 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 1056.52% in 2023, down 75.79% in 2023.
- Over 5 years, Prepaid Assets stood at $337812.0 in 2021, then tumbled by 72.77% to $92000.0 in 2022, then jumped by 1056.52% to $1.1 million in 2023, then soared by 48.21% to $1.6 million in 2024, then slumped by 75.14% to $392000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $392000.0, $1.5 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 562,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 577,000.00 |
| Mar 31, 2024 | 940,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 734,000.00 |
| Jun 30, 2023 | 150,721.00 |
| Mar 31, 2023 | 85,293.00 |
| Dec 31, 2022 | 92,000.00 |
| Sep 30, 2022 | 138,412.00 |
| Jun 30, 2022 | 240,536.00 |
| Mar 31, 2022 | 352,285.00 |
| Dec 31, 2021 | 337,812.00 |
| Sep 30, 2021 | 364,671.00 |
| Jun 30, 2021 | 391,533.00 |